Archives
Podcast: Approach to shortness of breath
21 Oct, 2020 | 09:06h | UTC
Position Statement: Standardizing care to manage bleeding disorders in adolescents with heavy menses
21 Oct, 2020 | 09:07h | UTC
Covid-19: The global crisis — in data
20 Oct, 2020 | 01:45h | UTCCovid-19: The global crisis — in data – Financial Times
WHO takes a position on genetically modified mosquitoes
21 Oct, 2020 | 09:02h | UTCWHO takes a position on genetically modified mosquitoes – World Health Organization
Position Statement: Evaluation of genetically modified mosquitoes for the control of vector-borne diseases – World Health Organization
[Abstract Only] Study: Excess days in acute care provide a more comprehensive picture of hospital performance compared to 30-day readmission rates
21 Oct, 2020 | 09:04h | UTCEvaluation of Hospital Performance Using the Excess Days in Acute Care Measure in the Hospital Readmissions Reduction Program – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Excess Days in Acute Care Provide More Comprehensive Picture of Hospital Performance Compared to 30-day Readmission Rates – AboutHealthTransparency.org AND EDAC: A ’More Comprehensive Picture of Hospital Use’ – Physician’s Weekly
Editorial: Covid-19’s known unknowns
20 Oct, 2020 | 01:42h | UTCCovid-19’s known unknowns – The BMJ
Commentary on Twitter
If you are going to read anything today let it be this short editorial @bmj_latest https://t.co/ggvEglehJm pic.twitter.com/hyw21BcZBU
— Maarten van Smeden (@MaartenvSmeden) October 19, 2020
Covid-19 vaccine protocols reveal that trials are designed to succeed
20 Oct, 2020 | 01:40h | UTCCovid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed – Forbes
Herd immunity and implications for SARS-CoV-2 control
20 Oct, 2020 | 01:44h | UTCHerd Immunity and Implications for SARS-CoV-2 Control – JAMA
Author Interview: Can We Count on Herd Immunity to Control COVID-19? – JAMA
Patient Page: What Is Herd Immunity? – JAMA
Commentary on Twitter
Herd immunity is real. It may be inevitable given our poor handling of COVID-19 and nature of the virus.
But to *deliberately* shoot for natural herd immunity (ie, without a vaccine) makes no sense.
Via @SaadOmer3 @InciYildirim11 @thehowie @JAMA_current https://t.co/PwWc1wMMzE pic.twitter.com/Ybn7vHFnt8
— Nicholas A. Christakis (@NAChristakis) October 19, 2020
Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
20 Oct, 2020 | 01:38h | UTC
Commentary on Twitter
Side effect of #COVID19 surge: ignoring well established strategies
➡️ limit ABTs exposure vs resistances: MV/long #ICU stay
➡️ avoid toxicity: antivirals/antibiotics can have severe adverse effects/interactions
➡️ high mortality: improving outcome crucial https://t.co/FN3LtKKlsr pic.twitter.com/7KGbIOH3Uf— Intensive Care Medicine (@yourICM) October 17, 2020
Opinion: The scientific and ethical feasibility of immunity passports
20 Oct, 2020 | 01:41h | UTCThe scientific and ethical feasibility of immunity passports – The Lancet Infectious Diseases
Related: Digital ‘health passport’ trials under way to aid reopening of borders – The Guardian
The household secondary attack rate of SARS-CoV-2: A rapid review
20 Oct, 2020 | 01:36h | UTCThe household secondary attack rate of SARS-CoV-2: A rapid review – Clinical Infectious Diseases
Commentary on Twitter
Household secondary attack rate (SAR) of #SARSCoV2 A rapid review https://t.co/u2YGZYB9Zt The overall pooled random-effects estimate of the household SAR was 17.1% (95% CI: 13.7-21.2%). Household SAR higher among older adult contacts and among contacts of symptomatic cases.
— Carlos del Rio (@CarlosdelRio7) October 16, 2020
Perspective: All eyes on a hurdle race for a SARS-CoV-2 vaccine
20 Oct, 2020 | 01:39h | UTCAll eyes on a hurdle race for a SARS-CoV-2 vaccine – Nature
Meta-analysis: The association of D-dimers with mortality, intensive care unit admission or ARDS in patients hospitalized with COVID-19
20 Oct, 2020 | 01:37h | UTC
AHA Scientific Statement: Contemporary diagnosis and management of rheumatic heart disease
20 Oct, 2020 | 01:34h | UTCTop Things to Know: Contemporary Diagnosis and Management of Rheumatic Heart Disease – American Heart Association
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
20 Oct, 2020 | 01:33h | UTCExecutive summary: 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment – Kidney International
Commentary on Twitter
2020 #KDIGO Diabetes Management in #CKD Guidelinehttps://t.co/G127PgO1fe@deboerih @P_Rossing @goKDIGO pic.twitter.com/3kVNDpAoub
— Kidney International (@Kidney_Int) October 4, 2020
Cohort study: Exposure to modafinil and armodafinil during pregnancy linked to fetal malformations
20 Oct, 2020 | 01:31h | UTCPregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy – JAMA Internal Medicine (free for a limited period)
Commentaries: Caution in Prescribing Modafinil and Armodafinil to Individuals Who Could Become Pregnant – JAMA Internal Medicine (free for a limited period) AND Narcolepsy Drugs Tied to Increased Risk for Birth Defects – NEJM Journal Watch
Vertical transmission of Zika virus and its outcomes: a Bayesian synthesis of prospective studies
20 Oct, 2020 | 01:30h | UTCCommentary: Desideratum: a developmentalist view of Zika virus infection – The Lancet Infectious Diseases
Plastic surgery complications: A review for emergency clinicians
20 Oct, 2020 | 01:32h | UTC
[Abstract Only] Systematic review and meta-analysis of native kidney biopsy complications
20 Oct, 2020 | 01:26h | UTCSystematic Review and Meta-Analysis of Native Kidney Biopsy Complications – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Commentary on Twitter
A meta-analysis found that although native kidney biopsy is an invasive diagnostic procedure, the rates of bleeding complications are low. Complications are more frequently seen after kidney biopsies of hospitalized patients with AKI. https://t.co/kxK6qxX1fc pic.twitter.com/SgCoI505cc
— CJASN (@CJASN) October 15, 2020
‘No evidence of effect’ versus ‘evidence of no effect’: how do they differ?
20 Oct, 2020 | 01:28h | UTC
Commentary on Twitter
What is the difference between ‘no evidence of effect’ vs ‘evidence of no effect’? @Elpida_Vnz discusses this important concept in a @Students4BE blog: https://t.co/0CCSclr0lH “Absence of evidence is not evidence of absence”.
— Cochrane (@cochranecollab) October 16, 2020
The Lancet: Latest global disease estimates reveal perfect storm of rising chronic diseases and public health failures fuelling COVID-19 pandemic
18 Oct, 2020 | 23:21h | UTCCommentaries: Global rise in chronic diseases combined with Covid-19 bodes ill for world health – CNN AND Global study shows deadly convergence of chronic disease, COVID-19 – CIDRAP
See report: NEW Special issue of The Global Burden of Disease Study 2019
Related Editorial: Global health: time for radical change? – The Lancet
Meta-analysis: Evidence-based prevention of Alzheimer’s disease
20 Oct, 2020 | 01:21h | UTCCommentaries: Biggest risk factors identified to try and prevent Alzheimer’s disease – BMJ AND Systematic review finds ten lifestyle factors that clearly impact the probability of developing Alzheimer’s disease (AD) – Sharp Brains
Commentary on Twitter
Evidence-based #prevention of #Alzheimers disease https://t.co/XOMiEoMlmI via @JNNP_BMJ #dementia @perryd43 @PennilessScribe @u3Y4BDE @SanWren @lfkraus @the_scholar1 @ktanimara @drsharwood @TargetLatino @LilithResists @Joseph_Santoro @liftdupbyangels @mrtom101 @SteveDitchfield pic.twitter.com/T5hqbzmIwi
— Ian Kremer (@LEAD_Coalition) July 24, 2020
[Abstract Only] Meta-analysis: Effect of urate-lowering therapy on cardiovascular and kidney outcomes
20 Oct, 2020 | 01:22h | UTCEffect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Commentary on Twitter
Study found urate-lowering therapy didn't produce benefits on clinical outcomes including major adverse cardiovascular events, all-cause mortality & kidney failure. Insufficient evidence to support urate lowering to improve kidney & cardiovascular outcomes https://t.co/uifm4vikYe pic.twitter.com/3fV60V3Lcx
— CJASN (@CJASN) October 14, 2020
[Preprint] Multi-organ impairment in low-risk individuals with long COVID
18 Oct, 2020 | 23:18h | UTCMulti-organ impairment in low-risk individuals with long COVID – medRxiv
Related study (preprint): Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services – medRxiv
Commentary on Twitter
"In a young, low-risk population with ongoing symptoms, almost 70% of individuals have impairment in 1 or more organs 4 months after initial symptoms of #SARSCoV2 infection" #LongCovid https://t.co/gPnDtacI1J by @amibanerjee1 and colleagues
via @ahandvanish<-🙏 pic.twitter.com/7mKEsQgq5l— Eric Topol (@EricTopol) October 17, 2020
Improving prone positioning for severe ARDS during the COVID-19 pandemic: An implementation mapping approach
18 Oct, 2020 | 23:17h | UTC
Commentary on Twitter
Improving Prone Positioning for Severe ARDS during the COVID-19 Pandemic: An Implementation Mapping Approach
✅ Just Accepted
🔗 https://t.co/V8K3MUdSWU pic.twitter.com/wPJCp2mKaE— Annals of the ATS (@AnnalsATS) October 13, 2020